WHO ICTRP trial

A multicenter, open label, comparative study to evaluate and compare Safety…

CTRI/2014/04/004543 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2014/04/004543
Public title A multicenter, open label, comparative study to evaluate and compare Safety, Tolerability And Immunogenicity Of 10-Valent Pneumococcal Polysaccharide Conjugate Vaccine in healthy infant
Scientific title A Randomized, Comparative, Open Labeled, Multicentric, Phase I Study To Evaluate And Compare The Safety, Tolerability And Immunogenicity Of Two Formulations (With And Without Preservative) Of 10-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Nucovac® Of Panacea Biotec Ltd. With…
Primary sponsor Panacea Biotec Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries India
Interventions Intervention1: Pneumococcal Polysaccharide Conjugate Vaccine with and without preservative.: 0.5 ml, Intramuscular, single dose Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed), 10-valent (1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F & 23F)…
Registration date Apr 16, 2014
Target size 72
Secondary IDs PBL/CR/2013/03/CT/NUCOI version 01 Dated 14-10-13
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations